The importance of alpha-fodrin antibodies in the diagnosis of Sjögren’s syndrome
Tóm tắt
Objective: We wanted to determine the prevalence of IgA and IgG antibodies against alpha-fodrin in the patients with primary and secondary Sjögren’s syndrome (SS) and also to compare with anti-Ro and anti-La antibodies in the diagnosis of SS. Methods: We tested the prevalence of anti-alpha-fodrin IgA, IgG, anti-Ro, anti-La antibodies, anti-nuclear antibodies (ANA) and rheumatoid factor (RF) in naive patients with primary (n=20) and secondary SS (n=20) (Rheumatoid Arthritis [RA]+SS, n=10; Systemic Lupus Erythematosus [SLE]+SS, n=10), RA (n=10), SLE (n=10) and in healthy controls (n=20). Salivary gland biopsies were performed in the patients with primary and secondary SS. Results: In primary SS, anti-alpha-fodrin IgA, IgG, anti-Ro and anti-La antibodies were detected as 20, 10, 55 and 20% respectively. In RA+SS, anti-alpha-fodrin IgA was detected to be 10% and IgG was negative; however, anti-Ro antibodies and anti-La antibodies were found to be 40% and 20% respectively. In SLE+SS, anti-alpha-fodrin IgA was found to be 20% and IgG was found to be 10%, but anti-Ro and anti-La antibodies were found to be 90% and 20% respectively. Alpha-fodrin antibodies were not detected in RA, SLE and healthy controls. Conclusion: The detection of anti-alpha-fodrin antibodies by used ELISA does not give much contribution to the diagnosis of SS, and anti-Ro and anti-La are still useful serological markers in the diagnosis of SS.
Tài liệu tham khảo
Pillemer SR, Matteson EL, Jacobson LT et al (2001) Incidence of physician-diagnosed primary Sjögren’s syndrome in residents of Olmsted Country, Minnesota. Mayo Clin Proc 76:593–598
Pillemer SR (2001) Sjögren’s Syndrome. In: Klippel JH (ed) Primer on the rheumatic disease, 12th edn. Arthritis Foundation, Atlanta, pp 377–384
Vitali C, Bombardieri S, Johnson R et al (2002) Classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American-European consensus group. Ann Rheum Dis 61:554–558
Haneji N, Nakamura T, Takai T et al (1997) Identification of alpha-fodrin as a candidate autoantigen in primary Sjogren’s syndrome. Science 276:604–607
Yanagi KN, Ishimaru N, Haneji N, Saegusa K, Saito I, Hayashi Y (1998) Anti-120-kDa α-fodrin immune response with Th1-cytokine profile in the NOD mouse model of Sjögren’s syndrome. Eur J Immunol 28:3336–3345
Watanabe T, Tsuchida T, Kanda N, Mori K, Hayashi Y, Tamaki K (1999) Anti-α-fodrin antibodies in Sjögren’s syndrome and lupus erythematosus. Arch Dermatol 135:535–539
Kobayashi I, Kawamura N, Okano M et al (2001) Anti-α-fodrin autoantibody is an early diagnostic marker for childhood primary Sjögren’s syndrome. J Rheumatol 28:363–365
Maeno N, Takei S, Imanaka H et al (2001) Anti-α-fodrin antibodies in Sjögren’s syndrome in children. J Rheumatol 28:860–864
Witte T, Matthias T, Arnett FC et al (2000) IgA and IgG autoantibodies against alpha-fodrin as markers for Sjogren’s syndrome. J Rheumatol 27:2617–2620
Arnett FC, Edworthy SM, Bloch DA et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324
Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus (letter). Arthritis Rheum 40:1725
St Clair EW, Burch JA, Saitta M (1994) Specificity of autoantibodies for recombinant 60-kd and 52-kd Ro autoantigens. Arthritis Rheum 37:1373–1380
Ishimaru N, Yanagi K, Ogawa K, Suda T, Saito I, Hayashi Y (2001) Possible role of organ- specific autoantigen for Fas Ligand-mediated activation-induced cell death in murine Sjögren’s syndrome. J Immunol 167:6031–6037
Zandbelt MM, Vogelzangs J, van de Putte LB, van Venrooij VJ, van den Hoogen FHJ (2004) Anti-α-fodrin antibodies do not add much to the diagnosis of Sjögren’s syndrome. Arthritis Res Ther 6:R33–R38